FindTrial
Sign In

Study on the Mechanism of HSP90AA1 Promoting Lung Adenocarcinoma Invasion and Metastasis through AKT Pathway

Study on the Mechanism of HSP90AA1 Promoting Lung Adenocarcinoma Invasion and Metastasis through AKT Pathway

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127003
Enrollment
Unknown
Registered
2026-06-22
Start date
2026-06-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung adenocarcinoma

Interventions

Primary lung adenocarcinoma:None
Distant metastatic lesions of lung adenocarcinoma:None

Sponsors

Fuzhou University Affiliated Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Archived paraffin-embedded tissue specimens of the primary lung adenocarcinoma and its distant metastases, confirmed by the Pathology Department.

Exclusion criteria

Exclusion criteria: 1. Specimens with incomplete clinical data; 2. Cases with concurrent other malignant tumors.

Design outcomes

Primary

MeasureTime frame
Expression of HSP90AA1 in primary and metastatic lung adenocarcinoma;—

Countries

China

Contacts

Public ContactKangmei Tong

Fuzhou University Affiliated Provincial Hospital

814760423@qq.com+86 591 8861 8965

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026